Skip to content
10-Q

Quarterly Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-21-001765

← back to feed
Filed
Aug 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Mar 31, 2020 100M sh
Current Liabilities Q1 2020 · Mar 31, 2020 $281.33K
Current Liabilities Q1 2020 · Dec 31, 2019 $269.88K
Total Liabilities Q1 2020 · Mar 31, 2020 $281.33K
Total Liabilities Q1 2020 · Dec 31, 2019 $269.88K
Current Assets Q1 2020 · Mar 31, 2020 $1.35K
Current Assets Q1 2020 · Dec 31, 2019 $1.35K
Total Assets Q1 2020 · Mar 31, 2020 $1.35K
Total Assets Q1 2020 · Dec 31, 2019 $1.35K
Operating Cash Flow Q1 2020 · Mar 31, 2019 $0
Cash And Equivalents Q1 2020 · Mar 31, 2019 $1.2K
Cash And Equivalents Q1 2020 · Dec 31, 2018 $1.2K
Stockholders Equity Q1 2020 · Mar 31, 2019 −$217.37K
Stockholders Equity Q1 2020 · Dec 31, 2018 −$196.76K
Sga Expense Q1 2020 · Mar 31, 2019 $20.61K
Net Income Q1 2020 · Mar 31, 2019 −$20.61K
Operating Income Q1 2020 · Mar 31, 2019 −$20.61K
Revenue Q1 2020 · Mar 31, 2019 $0